Argolyn Bioscience, Inc.'s Final Failure; Company in Chapter 7 Bankruptcy Dissolution

Triangle Business Journal -- Just six months ago and two years after attracting enough investor interest to gain a commitment of $15.8 million in venture financing, Argolyn Bioscience was preparing for clinical trials of its first product.